kabunushi
18 minutes ago
For context, Lemqembi cost and benefit: https://www.cbsnews.com/news/alzheimers-drug-leqembi-cost-patients-taxpayers/
In addition to the company's $26,500 annual price tag for the drug, treatment could cost U.S. taxpayers $82,500 per patient per year, on average, for genetic tests